Concepedia

Antje Habel

AH

Statistics

Publications

25

Citations

3.8K

H-Index

23

Active since

2007

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

German Cancer Research Center

Goethe University Frankfurt

Medical University of Vienna

Antje Habel is an author at Heidelberg University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2007–2024

25

Publications

25

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

Lukas Bunse, Stefan Pusch, Theresa Bunse et al. · Nature Medicine · 2018 · 537 citations

, , +12

Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain Tumors

David Capper, Susanne Weißert, Antje Habel et al. · Brain Pathology · 2009 · 523 citations · Full text

, , +17

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

David Capper, Matthias Preusser, Antje Habel et al. · Acta Neuropathologica · 2011 · 472 citations

, , +9

Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein

Leonille Schweizer, Christian Koelsche, Felix Sahm et al. · Acta Neuropathologica · 2013 · 383 citations

, , +10

Autonomous rhythmic activity in glioma networks drives brain tumour growth

David Hausmann, Dirk C. Hoffmann, Varun Venkataramani et al. · Nature · 2022 · 249 citations

, , +16

1–5 of 25